Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Finite element analysis and case series study of anchor loop plate fixation of patellar inferior pole sleeve avulsion fracture.

Scientific reports·2026

Same author

Mycoplasma pneumoniae infection impairs asthma control in pediatric patients and exacerbates allergic airway inflammation.

Respiratory research·2026

Same author

Clinical analysis of preoperative and postoperative anxiety and depression in patients with proximal humeral fractures.

BMC psychology·2026

Same author

Polysaccharide PSLP-1 from <i>Polygonatum sibiricum</i> Stems and Leaves Alleviates Depressive-like Behaviors and Modulates Gut Microbiota and Tryptophan Metabolism along the Gut-Brain Axis.

Journal of agricultural and food chemistry·2026

Same author

Artificial Crystalline-Amorphous Architecture Enables Continuous Ion Transport in Poly(Vinylidene Fluoride)-Based Solid-State Electrolytes.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Investigation of free radical grafting modification of whey protein isolate by polyphenols with different hydroxyl numbers.

International journal of biological macromolecules·2026

Search research articles

Related Experiment Video

Updated: May 13, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

CAR-T therapy in solid tumors.

Bing Du¹, Juliang Qin¹, Boxu Lin¹

¹Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.

|April 15, 2025

Summary

This summary is machine-generated.

Chimeric antigen receptor (CAR) T-cell therapy shows promise for solid tumors by improving T-cell persistence and targeting multiple antigens. Combining CAR-T therapy with other treatments may overcome tumor microenvironment challenges.

Keywords:

CAR-T gene editing solid tumor synthetic biology tumor microenvironment

More Related Videos

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Experiment Videos

Last Updated: May 13, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Area of Science:

Immunology
Oncology
Cell Therapy

Background:

CAR T-cell therapy is effective in blood cancers but faces challenges in solid tumors.
Key limitations include tumor antigenic heterogeneity and an immunosuppressive tumor microenvironment (TME).

Purpose of the Study:

To review advancements and challenges of CAR T-cell therapy for solid tumors.
To explore strategies for enhancing CAR T-cell efficacy in solid tumors.

Main Methods:

Review of clinical studies on CAR T-cell therapy for solid tumors.
Discussion of strategies to improve T-cell persistence, cytotoxicity, and antigen targeting.
Exploration of allogeneic CAR T-cell manufacturing and combination therapies.

Main Results:

CAR T-cell therapy for solid tumors is advancing, with strategies to overcome TME limitations being investigated.
Enhancing T-cell persistence, targeting multiple antigens, and using allogeneic CAR-T cells are key areas of development.
Combination therapies, including with immune checkpoint inhibitors, show potential.

Conclusions:

CAR T-cell therapy holds significant future potential for treating solid tumors.
Continued research is crucial to refine approaches and address patient clinical needs.